United States · FDA National Drug Code directory
Cetrorelix acetate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67184-0605_60fea8d3-ccd9-4714-80c5-b8f178f34ca3
- Product NDC
- 67184-0605
- Form
- KIT
- Composition / generic term
- Cetrorelix Acetate for Injection
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240416
- Source listing expiry
- 20261231
Source-listed ingredients
Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.
These values do not establish equivalence or a dose recommendation.
Packages
- 1 KIT in 1 CARTON (67184-0605-2) * 1 mL in 1 VIAL, GLASS (67184-0567-1) * 1 mL in 1 SYRINGE, GLASS (67184-0568-1) · 67184-0605-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →